학술논문
1111P A randomised phase II study of intermittent versus continuous dosing of targeted therapy in patients with BRAFV600 mutant advanced melanoma (INTERIM)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S669-S670
Subject
Language
ISSN
0923-7534